← Back to Patent Explorer
US4098777A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn

Assignee: Merck and Co Inc
•
Filing: 1977-03-14
•
Granted: 1978-07-04
•
Expires: 1997-03-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention is directed to the chemical process for the preparation of the polypeptide, pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn and to intermediates in said process. The polypeptide prepared by the present process is useful in the treatment of autoimmune diseases such as Lupus like pathology and specifically for the treatment of Lupus Erythematosus in man. This polypeptide is also useful for selectively stimulating T-cell activity in aging subjects.

Inventors

  • 👤 Daniel F. Veber
  • 👤 Robert G. Strachan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 17:46
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/06; C07K7/062; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/28

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 139 words
The process for the preparation of the peptide having the structure, < Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, which comprises converting the blocked heptapeptide hydrazide having the structure, < Glu-Ala-(ε-R)Lys-(O-R.sub.1 ')Ser-Gln-Gly-Gly-NH-NH.sub.2 to the corresponding azide and condensing said azide with the hydroxy blocked or unblocked dipeptide, (O-R.sub.2)Ser-Asn to obtain the blocked nonapeptide having the structure, < Glu-Ala-(ε-R)Lys-(O-R.sub.1 ')Ser-Gln-Gly-Gly-(O-R.sub.2)Ser-Asn wherein R is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl and isonicotinyloxycarbonyl, R 2 is hydrogen or a protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl, R 1 ' is hydrogen or a protecting group for the hydroxy group of the seryl moiety selected from the group consisting of t-butyl and benzyl, and removing said protecting groups.
Claim 2
Dependent Claim 139 words
The process for the preparation of the peptide having the structure, < Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, which comprises converting the blocked heptapeptide hydrazide having the structure, < Glu-Ala-(ε-R)Lys-(O-R.sub.1 ')Ser-Gln-Gly-Gly-NH-NH.sub.2 to the corresponding azide and condensing said azide with the hydroxy blocked or unblocked dipeptide, (O-R.sub.2)Ser-Asn to obtain the blocked nonapeptide having the structure, < Glu-Ala-(ε-R)Lys-(O-R.sub.1 ')Ser-Gln-Gly-Gly-(O-R.sub.2)Ser-Asn wherein R is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl and isonicotinyloxycarbonyl, R 2 is hydrogen or a protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl, R 1 ' is hydrogen or a protecting group for the hydroxy group of the seryl moiety selected from the group consisting of t-butyl and benzyl, and removing said protecting groups.
Claim 3
Dependent Claim 141 words
The process for the preparation of the peptide having the structure, < Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, which comprises condensing the blocked heptapeptide active ester having the structure, < Glu-Ala-(ε-R.sub.3)Lys-(O-R.sub.4 ')Ser-Gln-Gly-Gly-R.sub.6 with the hydroxy blocked or unblocked dipeptide, (O-R.sub.5)Ser-Asn wherein R 3 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of INOC, trifluoroacetyl, phthaloyl, tosyl, p-nitrobenzyloxycarbonyl, TROC and FMOC; R 4 ' is hydrogen, p-nitrobenzyl or benzoyl, R 5 is hydrogen or a protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzyl, substituted benzyl wherein the substituent is o-chloro or p-nitro; t-butyl and benzoyl, R 6 is an active ester selected from the group consisting of 1-hydroxybenzotriazole ester, N-hydroxysuccinimide ester and p-nitrophenyl ester, to obtain the blocked nonapeptide having the structure, < Glu-Ala-(ε-R.sub.3)Lys-(O-R.sub.4 ')Ser-Gln-Gly-Gly-(O-R.sub.5)Ser-Asn, and removing said blocking groups.
Claim 4
Dependent Claim 141 words
The process for the preparation of the peptide having the structure, < Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, which comprises condensing the blocked heptapeptide active ester having the structure, < Glu-Ala-(ε-R.sub.3)Lys-(O-R.sub.4 ')Ser-Gln-Gly-Gly-R.sub.6 with the hydroxy blocked or unblocked dipeptide, (O-R.sub.5)Ser-Asn wherein R 3 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of INOC, trifluoroacetyl, phthaloyl, tosyl, p-nitrobenzyloxycarbonyl, TROC and FMOC; R 4 ' is hydrogen, p-nitrobenzyl or benzoyl, R 5 is hydrogen or a protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzyl, substituted benzyl wherein the substituent is o-chloro or p-nitro; t-butyl and benzoyl, R 6 is an active ester selected from the group consisting of 1-hydroxybenzotriazole ester, N-hydroxysuccinimide ester and p-nitrophenyl ester, to obtain the blocked nonapeptide having the structure, < Glu-Ala-(ε-R.sub.3)Lys-(O-R.sub.4 ')Ser-Gln-Gly-Gly-(O-R.sub.5)Ser-Asn, and removing said blocking groups.
Claim 5
Dependent Claim 78 words
The process according to claim 1 for the preparation of the peptide having the structure, < Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, which comprises converting the blocked heptapeptide hydrazide having the structure, < Glu-Ala-(ε-INOC)Lys-(O-Bzl)Ser-Gln-Gly-Gly-NH-NH.sub.2 to the corresponding azide by the action of isoamyl nitrite and condensing said azide with the blocked dipeptide, (O-Bzl)Ser-Asn.HCl to obtain the blocked nonapeptide having the structure, < Glu-Ala-(ε-INOC)Lys-(O-Bzl)Ser-Gln-Gly-Gly-(O-Bzl)Ser-Asn and removing the benzyl group with hydrogen fluoride and anisole and removing the INOC group with hydrogen and Pd/C catalyst.
Claim 6
Dependent Claim 92 words
The compounds having the structure, Glu-Ala-(ε-R 8 )Lys-(O-R 9 )Ser-Gln-Gly-Gly-(O-R 10 )Ser-Asn wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 and R 10 are independently hydrogen or R 9 and R 10 are protecting groups for the hydroxy group of the seryl moieties, independently selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro.
Claim 7
Dependent Claim 92 words
The compounds having the structure, Glu-Ala-(ε-R 8 )Lys-(O-R 9 )Ser-Gln-Gly-Gly-(O-R 10 )Ser-Asn wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 and R 10 are independently hydrogen or R 9 and R 10 are protecting groups for the hydroxy group of the seryl moieties, independently selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro.
Claim 8
Dependent Claim 91 words
The compounds having the structure, < Glu-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-Gly-R.sub.7 wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro, R 7 is --NH--NH 2 , OH, 1-oxybenzotriazole, N-oxysuccinimide, p-nitrophenoxy or OCH 3 .
Claim 9
Dependent Claim 91 words
The compounds having the structure, < Glu-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-Gly-R.sub.7 wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro, R 7 is --NH--NH 2 , OH, 1-oxybenzotriazole, N-oxysuccinimide, p-nitrophenoxy or OCH 3 .
Claim 10
Dependent Claim 79 words
The compounds having the structure, < Glu(or BOC-Gln)-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-Gly-O-CH.sub.2 -φ-resin wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro.
Claim 11
Dependent Claim 79 words
The compounds having the structure, < Glu(or BOC-Gln)-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-Gly-O-CH.sub.2 -φ-resin wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro.
Claim 12
Dependent Claim 91 words
The compounds having the structure, < Glu-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-R.sub.7 wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro, R 7 is --NH--NH 2 , OH, 1-oxybenzotriazole, N-oxysuccinimide, p-nitrophenoxy or OCH 3 .
Claim 13
Dependent Claim 91 words
The compounds having the structure, < Glu-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-R.sub.7 wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro, R 7 is --NH--NH 2 , OH, 1-oxybenzotriazole, N-oxysuccinimide, p-nitrophenoxy or OCH 3 .
Claim 14
Dependent Claim 79 words
The compounds having the structure, < Glu(or BOC-Gln)-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-O-CH.sub.2 -φ-resin wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro.
Claim 15
Dependent Claim 79 words
The compounds having the structure, < Glu(or BOC-Gln)-Ala-(ε-R.sub.8)Lys-(O-R.sub.9)Ser-Gln-Gly-O-CH.sub.2 -φ-resin wherein R 8 is the protecting group for the ε-amino of the lysyl moiety selected from the group consisting of formyl, toluene sulfonyl, benzyloxycarbonyl; 2,6-dichlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2-chlorobenzyloxycarbonyl; 2,2,2-trichloroethoxycarbonyl, isonicotinyloxycarbonyl, trifluoroacetyl, phthaloyl, TROC and FMOC, R 9 is hydrogen or the protecting group for the hydroxy group of the seryl moiety, selected from the group consisting of benzoyl, t-butyl, benzyl and substituted benzyl wherein the substituent is o-chloro or p-nitro.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-07-03 1982-01-02 1982-07-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-07-03 1986-01-02 1986-07-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-07-03 1990-01-02 1990-07-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag